Flumazenil Injection, Solution
Product Images NDC 51662-1253

10 FDA label images from Hf Acquisition Co. Llc, Dba Health First · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 51662-1253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Flumazenil, showing its molecular arrangement with marked atoms and bonds typical of this active ingredient.*
FDA Label Image

Chart (Clinical Pharma Chart)

Chart (Clinical Pharma Chart)
A graph depicting the magnitude and duration of sedation reversal after intravenous Flumazenil injection at doses of 0.2, 0.6, and 1 mg. The y-axis shows alertness levels which include sedated, baseline sedation, awake, and completely alert states, while the x-axis indicates minutes after Flumazenil injection. The graph illustrates decreasing sedation over time, varying by dose, with higher doses leading to quicker reversal.*
FDA Label Image

Tabel (Clinica Pharma Tabel)

Tabel (Clinica Pharma Tabel)
A data table summarizing pharmacokinetic parameters including Cmax (ng/mL), AUC (ng·hr/mL), Vss (L/kg), Cl (L/hr/kg), and half-life (min) with mean values and ranges or variability percentages for each parameter.*
FDA Label Image

Warning Box (Warnings Box)

Warning Box (Warnings Box)
A text panel warning that the use of Flumazenil has been associated with seizures, especially in patients on long-term benzodiazepines or with serious cyclic antidepressant overdose. It advises practitioners to individualize dosage and be prepared to manage seizures.*
FDA Label Image

Vial (10 mL Vial Label)

Vial (10 mL Vial Label)
FLUMAZENIL injection, USP label for 1 mg/10 mL (0.1 mg/mL) intravenous injection solution. This 10 mL multiple dose vial is sterile, for IV use only, and RX only. The label lists composition details, storage instructions, and manufacturing information from HIKMA FarmacĂȘutica (Portugal) with distribution by West-Ward Pharmaceutical Corp. in Eatontown, NJ.*
FDA Label Image

Serialized Label (51662 1253 1 Flumazenil 10 Serialized Label)

Serialized Label (51662 1253 1 Flumazenil 10 Serialized Label)
Flumazenil injection, solution in a clear glass vial with a green cap. The label indicates a strength of 1 mg per 10 mL (0.1 mg/mL) for intravenous use. The vial is distributed by HF Acquisition Co., LLC, Mukilteo, WA. The label includes a 2D barcode and regulatory codes.*
FDA Label Image

Vial Label (1253 3 Vial)

Vial Label (1253 3 Vial)
Label for FLUMAZENIL injection, USP, 0.1 mg/mL (1 mg/10 mL) sterile solution in a 10 mL multiple dose vial. Intended for intravenous use only. Manufactured by Hikma Farmaceutica (Portugal) and distributed by West-Ward Pharmaceutical Corp, Eatontown, NJ. Includes storage instructions and barcode with NDC 0143-9783-01.*
FDA Label Image

Pouch Labeling (1253 2 Pouch)

Pouch Labeling (1253 2 Pouch)
Label for FLUMAZENIL injection solution, USP 1 mg/10 mL (0.1 mg/mL) vial by HF Acquisition Co., LLC, DBA Health First. The label includes the NDC 51662-1253-2, lot number, expiration date, and instructions indicating intravenous use only. Additional formulation and storage information are also present along with a QR code and manufacturer details from Mukilteo, WA.*
FDA Label Image

Case (1253 3 Case)

Case (1253 3 Case)
Label for FLUMAZENIL injection, USP 1 mg/10 mL (0.1 mg/mL) vial, packaged as a case of 10. The label includes the NDC 51662-1253 and batch information with lot number and expiration date. It indicates the product is for intravenous use, manufactured by HF Acquisition Co., LLC in Mukilteo, WA. The label also notes storage instructions and references the package insert for detailed information.*
FDA Label Image

Rfid Label (51662 1253 3 Rfid)

Rfid Label (51662 1253 3 Rfid)
Label for FLUMAZENIL injection solution, 0.1 mg/mL, manufactured and distributed by HF Acquisition Co. LLC, DBA Health First, Mukilteo, WA. The label includes a barcode, NDC 51662-1253, and standard manufacturing insert instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.